ALTSCHULLER Susan — SEC Form 4 filings
SEC reporting owner CIK 1817988. 7 Form 4 filings on record with FilingPulse; latest filed 2026-01-08.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-01-23 to 2026-01-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 10,000 shares, $32,071 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: purchase of 10,000 shares @ $3.21 ($32,071) in Mural Oncology plc, filed 2024-08-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Mural Oncology plc (MURA) | Director | 3 | 1 leg · 10,000 sh · $32,071 | — | 2 |
| Cerevel Therapeutics Holdings, Inc. (CERE) | Chief Financial Officer | 2 | — | — | 4 |
| Climb Bio, Inc. (CLYM) | Chief Financial Officer | 2 | — | — | 2 |
Form 4 filings — ALTSCHULLER Susan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-08 | 4 | Climb Bio, Inc. (CLYM) | Grant/award (A): 142,500 (derivative) @ $0 | EDGAR |
| 2025-10-01 | 4 | Climb Bio, Inc. (CLYM) | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2024-08-15 | 4 | Mural Oncology plc (MURA) | Purchase (P): 10,000 @ $3.21 | EDGAR |
| 2024-08-05 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Disposition to issuer (D): 16,913 · Disposition to issuer (D): 124,168 (derivative) · Disposition to issuer (D): 81,065 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4/A | Mural Oncology plc (MURA) | Grant/award (A): 8,462 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | Mural Oncology plc (MURA) | Grant/award (A): 8,462 (derivative) @ $3.35 | EDGAR |
| 2024-01-23 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Grant/award (A): 81,065 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1817988 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →